New York State Common Retirement Fund V Tv Therapeutics Inc. Transaction History

New York State Common Retirement Fund

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 02, 2021	SELL	$1.53 - $2.22 $192 - $279	-126 Closed	0 $0
Q2 2021 Aug 02, 2021	SELL	$2.27 - $3.44 $72,580 - $109,990	-31,974 Reduced 99.61%	126 $0
Q1 2021 May 11, 2021	SELL	$1.97 - $2.89 $18,321 - $26,877	-9,300 Reduced 22.46%	32,100 $91,000
Q2 2020 Aug 07, 2020	BUY	$1.74 - $3.19 $72,036 - $132,066	41,400 New	41,400 $93,000
Q2 2018 Aug 10, 2018	SELL	$0.71 - $4.04 $3,053 - $17,372	-4,300 Closed	0 $0

Q2 2017 Aug 11, 2017	BUY	N/A	4,300	4,300 $21,000

243K

Ticker VTVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 81,483,600
Market Cap $1.43B
Description
vTv Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on the development of orally administered treatments for diabetes. The company is developing TTP399, an orally administered, small molecule, and liver-selective glucokinase activator for the treatment of type 1 diabetes; and HPP737, an orally administered non-CNS penetran...

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.